Shona Whyte
Director, Search & Evaluation Novartis
Shona Whyte is the Director of Search & Evaluation for Radioligand Therapy at Novartis, a global healthcare company renowned for its innovative medicines and commitment to improving patient outcomes. In her role, Shona leads efforts to identify and evaluate strategic opportunities in radioligand therapies, aiming to enhance Novartis’s oncology portfolio. With extensive experience in business development and a deep understanding of radiopharmaceuticals, she excels at forging successful industry partnerships. Shona will be speaking on “Obtaining Winning Industry Partnerships to Advance Radiopharmaceutical Development,” sharing insights into collaborative strategies that drive innovation in this rapidly evolving field.
Seminars
The past year has seen a wealth of high-stake radiopharmaceutical M&As and investments, but what are the drivers of investor interest, and will these trends continue? Assessing how the growing market and high returns potential could unlock support for smaller biotech while identifying potential challenges.
Hear from the funding experts themselves on:
- Digging down on what the investors are interested in from targeting moiety, platform technology to payload
- Learning from industry stories to understand what it takes for a high-stakes investment
- Understanding what enhances radiopharmaceuticals commercial viability to attract more investment
- Exploring how to position and distinguish your technology’s platform capabilities
• Hearing from the experts on how to secure funding and industry partnerships
• Understanding how the process began and how to build relationships
